Related Experiment Video
Updated: Jan 7, 2026
12:37
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
18.7K
Risk factors and predictive score for phenytoin-induced cutaneous reactions
Chumpol Anamnart1, Ram Kitjarak2
1Division of Neurology, Department of Medicine, Prapokklao Hospital, 38 Leab Noen Rd, Tumbon Wat Mai, Mueang District, Chanthaburi City, 22000, Thailand. chumpolan@gmail.com.
Summary
This study identified key risk factors for phenytoin-induced cutaneous adverse drug reactions (CADRs) and developed a prediction score. The tool helps clinicians identify patients needing closer monitoring for these serious skin reactions.
Area of Science:
- Pharmacovigilance
- Clinical Risk Assessment
- Dermatology
Background:
- Phenytoin remains a widely used antiseizure medication globally.
- Cutaneous adverse drug reactions (CADRs) to phenytoin are a significant clinical concern, ranging from mild rashes to severe conditions.
Purpose of the Study:
- To identify clinical risk factors for phenytoin-induced CADRs.
- To develop and validate a clinical prediction score for these adverse events in hospitalized patients.
Main Methods:
- A retrospective cohort study of 447 adult patients receiving phenytoin for the first time.
- Logistic regression analysis identified independent risk factors.
- A clinical prediction score was developed and assessed using the area under the receiver operating characteristic curve (AuROC).
Main Results:
- 10.5% of patients developed CADRs.
- Independent risk factors included malignancy, HIV infection, alcohol dependence, and concurrent use of diazepam or carbapenems.
- The prediction score demonstrated good predictive ability (AuROC=0.856).
Conclusions:
- A validated clinical prediction score for phenytoin-induced CADRs was developed.
- This tool utilizes accessible clinical factors to identify high-risk patients.
- Further prospective studies are recommended for external validation and to confirm clinical utility.
Related Concept Videos
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
275
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
275
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
231
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
157
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
157
01:25Pharmacokinetics: Drug–Drug Interactions
313
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
313